TQB3303
/ Sino Biopharm, Shouyao Holdings
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 19, 2020
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
(clinicaltrials.gov)
- P1; N=40; Not yet recruiting; Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Clinical • New P1 trial
1 to 1
Of
1
Go to page
1